Related Experiment Video
Updated: Jan 30, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Diosgenin increased DDX3 expression in hepatocellular carcinoma
Hong Yu1, Yuanni Liu1, Chuanzhen Niu1
1Department of Liver Disease, Yantai Infectious Diseases Hospital Yantai, Shandong, China.
Abstract:
Liver cancer, one of the most common malignant tumors occurred worldwide, has emerged as a main health trouble and accounts for leading cancer-related death. Diosgenin is provided as an important material in the pharmaceutical industry, and is used to manage various medical troubles such as cancer because of its multiple bioactivities. DEAD box polypeptide 3 (DDX3) is involved in cancer biogenesis and modulates cancer progression. However, the role of DDX3 in human hepatocellular carcinoma (HCC) has not been fully understood. In the present study, we investigated the anti-tumor effects of diosgenin on HCC cells and whether DDX3 is involved in its antitumor activity. We observed that diosgenin dramatically inhibited cell proliferation, triggered apoptotic cell death, induced G2/M phase arrest, suppressed cell migration and invasion abilities. Moreover, the expression of DDX3 was measured and the results showed that DDX3 was significantly up-regulated upon diosgenin exposure. All together, our data indicated that diosgenin shows a cytotoxic effect on HCC cells and has potential therapeutic values for HCC patients.
Insights
Diosgenin exhibits potent anti-cancer effects against liver cancer by inhibiting cell proliferation and promoting cell death. This study reveals diosgenin
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Liver cancer is a major global health concern and a leading cause of cancer-related mortality.
- Diosgenin possesses known bioactivities and pharmaceutical applications, including anti-cancer properties.
- DEAD box polypeptide 3 (DDX3) is implicated in cancer development, but its specific role in hepatocellular carcinoma (HCC) requires further elucidation.
Purpose of the Study:
- To investigate the anti-tumor effects of diosgenin on human hepatocellular carcinoma (HCC) cells.
- To determine the involvement of DDX3 in the anti-cancer activity of diosgenin in HCC.
Main Methods:
- Cell proliferation assays were performed to assess diosgenin's impact on HCC cell growth.
- Apoptosis, cell cycle progression (G2/M phase arrest), migration, and invasion assays were conducted.
- DDX3 expression levels were measured in response to diosgenin treatment.
Main Results:
- Diosgenin significantly inhibited HCC cell proliferation and suppressed migration and invasion.
- Diosgenin induced apoptotic cell death and caused G2/M phase arrest in HCC cells.
- DDX3 expression was notably upregulated following diosgenin exposure.
Conclusions:
- Diosgenin demonstrates significant cytotoxic effects against HCC cells.
- Diosgenin exhibits potential therapeutic value for treating liver cancer.
- The study suggests DDX3 may play a role in diosgenin's anti-HCC mechanisms.
Related Concept Videos
Increasing Function
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
What is Gene Expression?

